TA

Trupti Avinash Pare

Active Director Director DIN 05199092
DIN 05199092 First appointment Mar 2014 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Mar 2014
Shareholding value •••• Premium profile

About Trupti Avinash Pare

Data last updated:

Trupti Avinash Pare is a Director at Saishree Vitalife Hospitals Private Limited (since 2014), Director at Bellpep Lifestyles Private Limited (since 2023) and Designated Partner at Samy Meditech Llp (since 2024). The companies operate in Healthcare and Consumer Products. The 2 current companies with reported revenue have a combined latest revenue of ₹48.11 Cr; the largest is Saishree Vitalife Hospitals Private Limited at ₹48.04 Cr (FY 2025). Earlier, Trupti Avinash Pare was a Director at Adkar And Pare Surgical International Private Limited (from 2017) and Director at Ssn Hospitals Private Limited (from 2018).

DIN 05199092
Primary Designation Director
Industry Healthcare
First Appointment 22 Mar 2014
Oldest Company Age 18 yrs
Largest company Saishree Vitalife Hospitals Private Limited · ₹48.04 Cr (FY 2025)
Combined revenue ₹48.11 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Mar 20142007₹48.04 Cr (FY 2025)Active
Bellpep Lifestyles Private Limited U47711PN2023PTC219787
Director21 Apr 20232023₹6.8 Lakh (FY 2025)Active
Designated Partner10 Oct 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Dec 20172017Strike Off
Ssn Hospitals Private Limited U74999PN2018PTC179597
Director15 Oct 20182018Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Adkar And Pare Surgical International Private Limited
Ssn Hospitals Private Limited
Saishree Vitalife Hospitals Private Limited
Bellpep Lifestyles Private Limited
Premium access

Shareholding and investment profile for Trupti Avinash Pare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Trupti Avinash Pare

Trupti Avinash Pare currently holds 3 directorships: Saishree Vitalife Hospitals Private Limited (Director, since 22 Mar 2014, revenue ₹48.04 Cr (FY 2025)); Bellpep Lifestyles Private Limited (Director, since 21 Apr 2023, revenue ₹6.8 Lakh (FY 2025)); Samy Meditech Llp (Designated Partner, since 10 Oct 2024).

Trupti Avinash Pare was first appointed on 22 Mar 2014 as Director at Saishree Vitalife Hospitals Private Limited. The most recent appointment on record is 10 Oct 2024 at Samy Meditech Llp.

The 2 current companies of Trupti Avinash Pare that report revenue have a combined latest revenue of ₹48.11 Cr: Saishree Vitalife Hospitals Private Limited ₹48.04 Cr (FY 2025); Bellpep Lifestyles Private Limited ₹6.8 Lakh (FY 2025).

Trupti Avinash Pare held 2 earlier board appointments: Adkar And Pare Surgical International Private Limited (Director, from 13 Dec 2017); Ssn Hospitals Private Limited (Director, from 15 Oct 2018).

The current boards of Trupti Avinash Pare's companies include Ashok Ramakrishna Kalluraya (Saishree Vitalife Hospitals Private Limited), Neeraj Arun Adkar (Saishree Vitalife Hospitals Private Limited), Niranjan Madhukar Narkhede (Saishree Vitalife Hospitals Private Limited), Yeshwant Shahuraj Mane (Saishree Vitalife Hospitals Private Limited), Ritu Vivek Gupta (Bellpep Lifestyles Private Limited), Sonal Niranjan Narkhede (Bellpep Lifestyles Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available